TISSUE FACTOR IN CIRRHOTIC AND HEPATOCELLULAR CARCINOMA PATIENTS

VALUE OF SERUM ALPHA L FUCOSIDASE LEVEL AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA BEFORE AND AFTER CHEMO-EMBOLIZATION AND RADIO-FREQUENCY, A PROSPECTIVE STUDY

Diagnostic Value of Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor-AB Circulating Levels in Hepatitis C Virus-Associated Hepatocellular Carcinoma

SERUM LEVEL OF HEPCIDIN IN CIRRHOTIC PATIENTS AS A MARKER FOR HEPATOCELLULAR CARCINOMA

THE DIAGNOSTIC VALUE OF CIRCULATING TUMOR NECROSIS FACTOR ALPHA (TNFa) VERSUS ALPHA FETOPROTEIN (AFP) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Angiopoietin-2 as a diagnostic biomarker for Liver cirrhosis and Hepatocellular Carcinoma

Clinical Significance of Serum Angiopoietin 2 in Patients with Hepatocellular Carcinoma

TELOMERASE AS A TUMOR MARKER IN HEPATOCELLULAR CARCINOMA

Value of Ascitic Fluid Lactoferrin in Diagnosis of Hepatocellular Carcinoma

A COMPARATIVE STUDY OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF GOLGI PROTEIN 73 AND ALFA-FETO PROTEIN IN HEPATOCELLULAR CARCINOMA BEFORE AND AFTER THERAPEUTIC INTERVENTION